Check your medicine cabinet.
More than 11,100 bottles of blood pressure medication sold under the brand name Ziac are being recalled due to cross-contamination with other medications, according to the U.S. Food and Drug Administration.
New Jersey-based Glenmark Pharmaceuticals is recalling 11,136 bottles of bisoprolol fumarate and hydrochlorothiazide tablets because they contain “traces of ezetimibe, a drug used to treat high cholesterol,” according to the FDA.
advertise
advertise
No adverse effects have been reported to date.
Read more: FDA recalls 580,000 bottles of this blood pressure drug: Is your drug on the list?
Here’s what you need to know about the recalled pills and what you should do if you have the recalled medication.
Which Ziac pills are recalled?
According to the FDA, the affected Ziac tablets are available in 2.5 mg and 6.25 mg strengths in the following package quantities:
-
30 bottles NDC 68462-878-30
-
100 bottles NDC-68462-878-01
-
500 bottles NDC68462-878-05
Affected drug batch numbers include:
-
Lot number 17232401, expiration date 11/2025
-
Lot number 17240974, expiry date 05/2026
-
Lot number 17232401, expiration date 11/2025
-
Lot number 17240974, expiry date 05/2026
-
Lot number 17232401, expiration date 11/2025
-
Lot number 17240974, expiry date 05/2026
advertise
advertise
The FDA classified the recall as a Class III recall on December 1, after first announcing the recall on November 21.
The FDA defines Class III recalls of products as “unlikely to cause adverse health consequences.”
If people think they have recalled Ziac pills in their medicine cabinet, they should contact their healthcare provider before taking any further doses.
Other recalls to check
Read the original article on NJ.com. Click here to add NJ.com as your preferred source.
